Filing Details
- Accession Number:
- 0001447362-21-000259
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-17 18:08:03
- Reporting Period:
- 2021-11-15
- Accepted Time:
- 2021-11-17 18:08:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239501 | J Derek Maetzold | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Suite 401 Friendswood TX 77546 | Pres. & Chief Exec. Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-15 | 16,406 | $2.36 | 302,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-15 | 15,394 | $52.47 | 287,030 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-15 | 1,012 | $53.04 | 286,018 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-16 | 15,409 | $3.72 | 301,427 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2021-11-15 | 16,406 | $0.00 | 16,406 | $2.36 |
| Common Stock | Stock option (right to buy) | Disposition | 2021-11-16 | 15,409 | $0.00 | 15,409 | $3.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-07-20 | No | 4 | M | Direct | |
| 20,686 | 2024-03-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 150,567 | Indirect | By The Maetzold Descendants 2020 Trust |
| Common Stock | 127,728 | Indirect | By DJM Grantor Retained Annuity Trust No. 1 |
| Common Stock | 137,965 | Indirect | By Derek Maetzold 2020 Irrevocable Trust |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $52.000 to $52.995, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $53.000 to $53.170, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.
- Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.
- Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.
- The shares subject to the option are fully vested.
Billionaire Hedge Funds
